Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).
Liquidity ratio | Description | The company |
---|---|---|
Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Abiomed Inc. current ratio improved from Q4 2022 to Q1 2023 and from Q1 2023 to Q2 2023. |
Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Abiomed Inc. quick ratio improved from Q4 2022 to Q1 2023 and from Q1 2023 to Q2 2023. |
Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Abiomed Inc. cash ratio improved from Q4 2022 to Q1 2023 and from Q1 2023 to Q2 2023. |
Current Ratio
Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||||||
Current assets | 1,062,798) | 1,060,359) | 976,473) | 885,006) | 871,487) | 729,873) | 787,965) | 693,691) | 716,621) | 619,689) | 635,863) | 636,576) | 647,432) | 677,365) | 677,197) | 628,728) | 561,599) | 497,297) | 494,271) | 422,198) | 370,170) | 350,915) | 326,958) | 333,419) | 319,870) | 300,288) | ||||||||
Current liabilities | 134,060) | 140,762) | 138,457) | 126,796) | 114,022) | 113,123) | 128,969) | 120,400) | 105,213) | 110,379) | 131,885) | 126,259) | 112,229) | 100,201) | 105,998) | 92,980) | 81,979) | 76,678) | 84,682) | 75,353) | 63,358) | 59,005) | 69,617) | 58,871) | 51,922) | 43,219) | ||||||||
Liquidity Ratio | ||||||||||||||||||||||||||||||||||
Current ratio1 | 7.93 | 7.53 | 7.05 | 6.98 | 7.64 | 6.45 | 6.11 | 5.76 | 6.81 | 5.61 | 4.82 | 5.04 | 5.77 | 6.76 | 6.39 | 6.76 | 6.85 | 6.49 | 5.84 | 5.60 | 5.84 | 5.95 | 4.70 | 5.66 | 6.16 | 6.95 | ||||||||
Benchmarks | ||||||||||||||||||||||||||||||||||
Current Ratio, Competitors2 | ||||||||||||||||||||||||||||||||||
Abbott Laboratories | 1.64 | 1.68 | 1.63 | 1.86 | 2.01 | 1.85 | 1.85 | 1.83 | 1.79 | 1.75 | 1.72 | 1.70 | 1.57 | 1.43 | 1.44 | 1.54 | 1.68 | 1.58 | — | — | — | — | — | — | — | — | ||||||||
Cigna Group | 0.73 | 0.72 | 0.73 | 0.73 | 0.83 | 0.81 | 0.83 | 0.70 | 0.72 | 0.76 | 0.77 | 0.79 | 0.83 | 0.76 | 0.74 | 0.61 | 0.65 | 0.64 | — | — | — | — | — | — | — | — | ||||||||
CVS Health Corp. | 0.86 | 0.92 | 0.94 | 0.94 | 0.91 | 0.88 | 0.88 | 0.94 | 0.95 | 0.93 | 0.91 | 0.95 | 0.98 | 0.99 | 0.94 | 0.92 | 0.95 | 0.95 | — | — | — | — | — | — | — | — | ||||||||
Elevance Health Inc. | 1.44 | 1.43 | 1.40 | 1.35 | 1.36 | 1.36 | 1.47 | 1.48 | 1.49 | 1.57 | 1.55 | 1.59 | 1.64 | 1.53 | 1.65 | 1.70 | 1.64 | 1.61 | — | — | — | — | — | — | — | — | ||||||||
Humana Inc. | 1.37 | 1.39 | 1.52 | 1.35 | 1.53 | 1.53 | 1.62 | 1.72 | 1.71 | 1.67 | 1.77 | 1.81 | 1.69 | 1.66 | 1.82 | 1.83 | 1.75 | 1.65 | — | — | — | — | — | — | — | — | ||||||||
Intuitive Surgical Inc. | 5.22 | 5.26 | 4.40 | 5.10 | 5.36 | 5.22 | 5.08 | 5.58 | 5.99 | 6.71 | 6.86 | 7.04 | 6.38 | 4.96 | 4.53 | 4.64 | 5.04 | 5.44 | — | — | — | — | — | — | — | — | ||||||||
Medtronic PLC | 1.76 | 1.58 | 1.86 | 2.61 | 2.91 | 2.89 | 2.65 | 2.10 | 2.16 | 1.87 | 2.13 | 2.75 | 2.77 | 2.67 | 2.59 | 2.36 | 2.56 | 2.46 | 2.28 | 2.43 | 2.40 | 1.64 | — | — | — | — | ||||||||
Shockwave Medical Inc. | 5.69 | 4.16 | 7.25 | 7.29 | 5.32 | 6.07 | 5.54 | 6.36 | 6.66 | 6.96 | 9.63 | 12.21 | 14.90 | 10.53 | 9.03 | 6.76 | 9.13 | 10.37 | — | — | — | — | — | — | — | — | ||||||||
UnitedHealth Group Inc. | 0.80 | 0.81 | 0.77 | 0.82 | 0.77 | 0.78 | 0.79 | 0.77 | 0.77 | 0.74 | 0.74 | 0.82 | 0.84 | 0.75 | 0.69 | 0.70 | 0.67 | 0.73 | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).
1 Q2 2023 Calculation
Current ratio = Current assets ÷ Current liabilities
= 1,062,798 ÷ 134,060 = 7.93
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Abiomed Inc. current ratio improved from Q4 2022 to Q1 2023 and from Q1 2023 to Q2 2023. |
Quick Ratio
Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||||||
Cash and cash equivalents | 182,335) | 180,492) | 132,818) | 144,255) | 241,882) | 175,454) | 232,710) | 181,018) | 202,241) | 214,827) | 192,341) | 117,970) | 150,279) | 101,048) | 121,021) | 84,181) | 76,382) | 61,288) | 42,975) | 50,502) | 44,536) | 43,970) | 39,040) | 61,069) | 54,709) | 38,274) | ||||||||
Short-term marketable securities | 638,037) | 663,829) | 625,789) | 524,966) | 408,677) | 347,577) | 350,985) | 305,434) | 330,843) | 212,536) | 250,775) | 309,569) | 295,041) | 385,624) | 370,677) | 373,975) | 334,064) | 299,228) | 319,274) | 250,751) | 218,661) | 207,441) | 190,908) | 179,640) | 178,236) | 184,900) | ||||||||
Accounts receivable, net | 94,475) | 91,102) | 90,608) | 88,952) | 89,568) | 88,645) | 97,179) | 92,990) | 80,909) | 82,084) | 84,650) | 100,994) | 94,319) | 86,206) | 90,809) | 88,215) | 74,201) | 67,511) | 70,010) | 64,862) | 57,327) | 53,557) | 54,055) | 50,178) | 46,607) | 41,280) | ||||||||
Total quick assets | 914,847) | 935,423) | 849,215) | 758,173) | 740,127) | 611,676) | 680,874) | 579,442) | 613,993) | 509,447) | 527,766) | 528,533) | 539,639) | 572,878) | 582,507) | 546,371) | 484,647) | 428,027) | 432,259) | 366,115) | 320,524) | 304,968) | 284,003) | 290,887) | 279,552) | 264,454) | ||||||||
Current liabilities | 134,060) | 140,762) | 138,457) | 126,796) | 114,022) | 113,123) | 128,969) | 120,400) | 105,213) | 110,379) | 131,885) | 126,259) | 112,229) | 100,201) | 105,998) | 92,980) | 81,979) | 76,678) | 84,682) | 75,353) | 63,358) | 59,005) | 69,617) | 58,871) | 51,922) | 43,219) | ||||||||
Liquidity Ratio | ||||||||||||||||||||||||||||||||||
Quick ratio1 | 6.82 | 6.65 | 6.13 | 5.98 | 6.49 | 5.41 | 5.28 | 4.81 | 5.84 | 4.62 | 4.00 | 4.19 | 4.81 | 5.72 | 5.50 | 5.88 | 5.91 | 5.58 | 5.10 | 4.86 | 5.06 | 5.17 | 4.08 | 4.94 | 5.38 | 6.12 | ||||||||
Benchmarks | ||||||||||||||||||||||||||||||||||
Quick Ratio, Competitors2 | ||||||||||||||||||||||||||||||||||
Abbott Laboratories | 1.00 | 1.07 | 1.06 | 1.22 | 1.33 | 1.21 | 1.28 | 1.25 | 1.19 | 1.16 | 1.14 | 1.01 | 0.93 | 0.83 | 0.88 | 0.93 | 0.98 | 0.94 | — | — | — | — | — | — | — | — | ||||||||
Cigna Group | 0.61 | 0.59 | 0.58 | 0.61 | 0.52 | 0.48 | 0.48 | 0.58 | 0.59 | 0.64 | 0.66 | 0.46 | 0.50 | 0.42 | 0.41 | 0.51 | 0.53 | 0.53 | — | — | — | — | — | — | — | — | ||||||||
CVS Health Corp. | 0.59 | 0.61 | 0.62 | 0.64 | 0.62 | 0.54 | 0.55 | 0.59 | 0.58 | 0.54 | 0.53 | 0.58 | 0.63 | 0.60 | 0.52 | 0.52 | 0.54 | 0.55 | — | — | — | — | — | — | — | — | ||||||||
Elevance Health Inc. | 1.32 | 1.31 | 1.27 | 1.21 | 1.22 | 1.23 | 1.33 | 1.33 | 1.35 | 1.43 | 1.42 | 1.45 | 1.49 | 1.37 | 1.52 | 1.58 | 1.51 | 1.49 | — | — | — | — | — | — | — | — | ||||||||
Humana Inc. | 1.16 | 1.18 | 1.20 | 1.13 | 1.21 | 1.21 | 1.20 | 1.32 | 1.28 | 1.26 | 1.37 | 1.47 | 1.35 | 1.29 | 1.47 | 1.51 | 1.36 | 1.32 | — | — | — | — | — | — | — | — | ||||||||
Intuitive Surgical Inc. | 4.36 | 4.30 | 3.56 | 4.19 | 4.49 | 4.40 | 4.34 | 4.66 | 5.12 | 5.76 | 5.96 | 5.93 | 5.40 | 4.00 | 3.75 | 3.80 | 4.15 | 4.53 | — | — | — | — | — | — | — | — | ||||||||
Medtronic PLC | 1.18 | 1.01 | 1.30 | 1.87 | 2.07 | 2.06 | 1.91 | 1.58 | 1.63 | 1.37 | 1.50 | 2.05 | 2.02 | 1.95 | 1.90 | 1.69 | 1.88 | 1.83 | 1.71 | 1.85 | 1.84 | 1.25 | — | — | — | — | ||||||||
Shockwave Medical Inc. | 4.43 | 3.53 | 5.93 | 5.81 | 4.30 | 4.88 | 4.62 | 5.29 | 5.55 | 5.88 | 8.37 | 10.70 | 13.40 | 9.50 | 8.44 | 6.17 | 8.47 | 9.72 | — | — | — | — | — | — | — | — | ||||||||
UnitedHealth Group Inc. | 0.74 | 0.75 | 0.70 | 0.77 | 0.71 | 0.72 | 0.72 | 0.71 | 0.71 | 0.68 | 0.68 | 0.75 | 0.76 | 0.66 | 0.63 | 0.64 | 0.62 | 0.66 | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).
1 Q2 2023 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 914,847 ÷ 134,060 = 6.82
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Abiomed Inc. quick ratio improved from Q4 2022 to Q1 2023 and from Q1 2023 to Q2 2023. |
Cash Ratio
Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||||||
Cash and cash equivalents | 182,335) | 180,492) | 132,818) | 144,255) | 241,882) | 175,454) | 232,710) | 181,018) | 202,241) | 214,827) | 192,341) | 117,970) | 150,279) | 101,048) | 121,021) | 84,181) | 76,382) | 61,288) | 42,975) | 50,502) | 44,536) | 43,970) | 39,040) | 61,069) | 54,709) | 38,274) | ||||||||
Short-term marketable securities | 638,037) | 663,829) | 625,789) | 524,966) | 408,677) | 347,577) | 350,985) | 305,434) | 330,843) | 212,536) | 250,775) | 309,569) | 295,041) | 385,624) | 370,677) | 373,975) | 334,064) | 299,228) | 319,274) | 250,751) | 218,661) | 207,441) | 190,908) | 179,640) | 178,236) | 184,900) | ||||||||
Total cash assets | 820,372) | 844,321) | 758,607) | 669,221) | 650,559) | 523,031) | 583,695) | 486,452) | 533,084) | 427,363) | 443,116) | 427,539) | 445,320) | 486,672) | 491,698) | 458,156) | 410,446) | 360,516) | 362,249) | 301,253) | 263,197) | 251,411) | 229,948) | 240,709) | 232,945) | 223,174) | ||||||||
Current liabilities | 134,060) | 140,762) | 138,457) | 126,796) | 114,022) | 113,123) | 128,969) | 120,400) | 105,213) | 110,379) | 131,885) | 126,259) | 112,229) | 100,201) | 105,998) | 92,980) | 81,979) | 76,678) | 84,682) | 75,353) | 63,358) | 59,005) | 69,617) | 58,871) | 51,922) | 43,219) | ||||||||
Liquidity Ratio | ||||||||||||||||||||||||||||||||||
Cash ratio1 | 6.12 | 6.00 | 5.48 | 5.28 | 5.71 | 4.62 | 4.53 | 4.04 | 5.07 | 3.87 | 3.36 | 3.39 | 3.97 | 4.86 | 4.64 | 4.93 | 5.01 | 4.70 | 4.28 | 4.00 | 4.15 | 4.26 | 3.30 | 4.09 | 4.49 | 5.16 | ||||||||
Benchmarks | ||||||||||||||||||||||||||||||||||
Cash Ratio, Competitors2 | ||||||||||||||||||||||||||||||||||
Abbott Laboratories | 0.57 | 0.66 | 0.66 | 0.74 | 0.75 | 0.65 | 0.78 | 0.75 | 0.71 | 0.67 | 0.60 | 0.46 | 0.46 | 0.34 | 0.38 | 0.41 | 0.37 | 0.36 | — | — | — | — | — | — | — | — | ||||||||
Cigna Group | 0.22 | 0.20 | 0.17 | 0.19 | 0.11 | 0.12 | 0.14 | 0.13 | 0.15 | 0.24 | 0.32 | 0.15 | 0.20 | 0.13 | 0.14 | 0.17 | 0.17 | 0.20 | — | — | — | — | — | — | — | — | ||||||||
CVS Health Corp. | 0.21 | 0.24 | 0.23 | 0.28 | 0.22 | 0.16 | 0.18 | 0.20 | 0.17 | 0.15 | 0.18 | 0.19 | 0.27 | 0.21 | 0.15 | 0.14 | 0.17 | 0.16 | — | — | — | — | — | — | — | — | ||||||||
Elevance Health Inc. | 0.92 | 0.91 | 0.86 | 0.87 | 0.86 | 0.86 | 0.95 | 0.97 | 0.97 | 1.08 | 1.04 | 1.04 | 1.10 | 0.95 | 1.08 | 1.14 | 1.07 | 1.04 | — | — | — | — | — | — | — | — | ||||||||
Humana Inc. | 1.11 | 1.06 | 1.10 | 1.07 | 1.02 | 1.02 | 1.08 | 1.20 | 1.12 | 1.12 | 1.29 | 1.39 | 1.22 | 1.16 | 1.37 | 1.44 | 1.28 | 1.15 | — | — | — | — | — | — | — | — | ||||||||
Intuitive Surgical Inc. | 3.77 | 3.59 | 2.90 | 3.50 | 3.78 | 3.58 | 3.66 | 3.98 | 4.42 | 5.04 | 5.30 | 5.27 | 4.85 | 3.44 | 3.13 | 3.11 | 3.37 | 3.79 | — | — | — | — | — | — | — | — | ||||||||
Medtronic PLC | 0.79 | 0.63 | 0.85 | 1.26 | 1.37 | 1.36 | 1.27 | 1.17 | 1.18 | 0.99 | 1.06 | 1.33 | 1.27 | 1.25 | 1.16 | 1.03 | 1.20 | 1.21 | 1.11 | 1.32 | 1.29 | 0.86 | — | — | — | — | ||||||||
Shockwave Medical Inc. | 3.22 | 2.94 | 4.80 | 4.62 | 3.40 | 3.94 | 3.89 | 4.54 | 4.85 | 5.30 | 7.91 | 10.19 | 13.04 | 9.08 | 8.14 | 5.88 | 8.13 | 9.45 | — | — | — | — | — | — | — | — | ||||||||
UnitedHealth Group Inc. | 0.44 | 0.43 | 0.36 | 0.46 | 0.36 | 0.37 | 0.36 | 0.35 | 0.35 | 0.33 | 0.33 | 0.37 | 0.42 | 0.35 | 0.28 | 0.30 | 0.32 | 0.32 | — | — | — | — | — | — | — | — |
Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).
1 Q2 2023 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 820,372 ÷ 134,060 = 6.12
2 Click competitor name to see calculations.
Liquidity ratio | Description | The company |
---|---|---|
Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Abiomed Inc. cash ratio improved from Q4 2022 to Q1 2023 and from Q1 2023 to Q2 2023. |